Brief: Chordate Medical Provides Update From Pm007 Multicenter Clinical Study Of K.O.S-Stimulation
Sept 8 (Reuters) - Chordate Medical Holding publ AB
CMHM.ST :
* STATISTICALLY SIGNIFICANT REDUCTION IN NUMBER OF HEADACHE
DAYS
SHOWN IN SUBGROUP ANALYSIS OF CHORDATE’S PM007 MULTICENTER
CLINICAL STUDY OF K.O.S-STIMULATION FOR PREVENTIVE TREATMENT OF
CHRONIC MIGRAINE
Source text for Eikon: ID:nMFN75yvJg
Further company coverage: CMHM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln